Skip to main content

Therapeutics

Therapeutics

Modifi Biosciences

Small molecule Wnt inhibition: First-in-class therapy for atherosclerosis

A new version of CAR with improved antigen sensitivity

Engineering Beta Cells for Resistance to Immune Attack and Reversal of Diabetes

Extended Release Latanoprost Wafer for the Treatment of Glaucoma

Epiregulin Inhibition to Treat Scleroderma Skin and Lung Fibrosis

ReImmune: A Disposable Bed-Side Device for T cell Immunotherapy without Genetic Engineering

To Identify a New Class of Therapeutics for Inflammatory Diseases

Potentiators of AntiMicrobial Susceptibility

Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis

Subscribe to Therapeutics